Rainbow Children's Medicare Limited

Yield per half year: -1.58%
Dividend yield: 0.2084%
Sector: Healthcare

Rainbow Children's Medicare Limited

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
2/10
56.82 101.26 -43.89% 48.45 +17.29%
P/S 9.12 13.09 -30.28%
P/BV 9.42 6.58 43.27%
P/FCF 55.33 31.47 75.79%
Ev/Ebitda 32.89 16.9 94.6%
Ev/S 9.49 10.1 -6.06%
Ev/FCF 57.55 32.61 76.49%
E/P 0.0176 0.0314 -43.96%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
8/10
28.86 -6.64 -534.46% 30.09 -4.11%
ROE 16.58 15.84 4.66%
ROA 10.24 7.66 33.67%
ROIC 12.23 15.5 -21.15%
ROS 16.06 -15.15 -206.01%
ROCE 23.83 17.75 34.29%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
7/10
1.75 1.13 53.96% 1.47 +18.66%
Nеt Debt/Ebitda 1.7 0.3504 384.96%
Debt/Ratio 0.3212 0.1597 101.12%
Debt/Equity 0.6115 0.6505 -6%
Debt/Net Income 3.14 28.22 -88.88%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0.53/10
0.2084 0.6029 -65.43% 0.2435 -14.41%
Number of years of dividend growth 0 1.26 -100%
DSI 1 0.8357 19.65%
Average dividend growth 11.11 -68.14 -116.31%
Average percentage for 5 years 0.2435 5.8 -95.8%
Average percentage for payments 15.55 24.02 -35.27%
Difference from average difference in sector -0.3945

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
136.86 206.21 -33.63%
Growth impulse Ebitda in 5 years 154.13 230.99 -33.27%
Growth impulse Net Income in 5 years 508.29 217.1 134.13%
Growth impulse FCF in 5 years 275.3 151.51 81.7%
Growth impulse EPS in 5 years 513.66 228.35 124.94%
IP Score
6.01/10

Similar companies

Torrent Pharmaceuticals Limited

Dr. Reddy's Laboratories Limited

Sun Pharmaceutical Industries Limited

Cipla Limited

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription